SG163540A1 - Substituted glycinamides having an antithrombotic and factor xa- inhibiting effect - Google Patents

Substituted glycinamides having an antithrombotic and factor xa- inhibiting effect

Info

Publication number: SG163540A1
Authority: SG; Singapore
Prior art keywords: antithrombotic; factor; inhibiting effect; substituted glycinamides; glycinamides
Prior art date: 2005-06-30

Application number

SG201004677-9A

Other languages

English (en)

Inventor

Henning Priepke

Georg Dahmann

Kai Gerlach

Roland Pfau

Wolfgang Wienen

Annette Schuler-Metz

Sandra Handschuh

Herbert Nar

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-30

Filing date

2006-06-28

Publication date

2010-08-30

2006-06-28 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2010-08-30 Publication of SG163540A1 publication Critical patent/SG163540A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Dermatology (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

SG201004677-9A 2005-06-30 2006-06-28 Substituted glycinamides having an antithrombotic and factor xa- inhibiting effect SG163540A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP05014270		2005-06-30

Publications (1)

Publication Number	Publication Date
SG163540A1 true SG163540A1 (en)	2010-08-30

Family

ID=35907001

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG201004677-9A SG163540A1 (en)	2005-06-30	2006-06-28	Substituted glycinamides having an antithrombotic and factor xa- inhibiting effect

Country Status (32)

Country	Link
US (3)	US20100216769A1 (es)
EP (1)	EP1899330B9 (es)
JP (1)	JP4768016B2 (es)
KR (1)	KR101321722B1 (es)
CN (1)	CN101213195B (es)
AR (1)	AR054627A1 (es)
AT (1)	ATE489381T1 (es)
AU (1)	AU2006265216B2 (es)
BR (1)	BRPI0612580A8 (es)
CA (1)	CA2613059C (es)
CY (1)	CY1111627T1 (es)
DE (1)	DE502006008392D1 (es)
DK (1)	DK1899330T3 (es)
EA (1)	EA015188B1 (es)
EC (1)	ECSP078058A (es)
ES (1)	ES2357029T3 (es)
HR (1)	HRP20110044T2 (es)
IL (1)	IL188323A (es)
MX (1)	MX2007016253A (es)
MY (1)	MY145883A (es)
NO (1)	NO340670B1 (es)
NZ (1)	NZ565440A (es)
PE (1)	PE20070171A1 (es)
PL (1)	PL1899330T3 (es)
PT (1)	PT1899330E (es)
RS (1)	RS51572B (es)
SG (1)	SG163540A1 (es)
SI (1)	SI1899330T1 (es)
TW (1)	TWI392495B (es)
UA (1)	UA94910C2 (es)
WO (1)	WO2007003536A1 (es)
ZA (1)	ZA200708525B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2582235A1 (en)	2004-10-04	2006-04-20	Millennium Pharmaceuticals, Inc.	Lactam compounds useful as protein kinase inhibitors
PE20080145A1 (es)	2006-03-21	2008-02-11	Janssen Pharmaceutica Nv	Tetrahidro-pirimidoazepinas como moduladores de trpv1
JP2009543812A (ja) *	2006-07-20	2009-12-10	キャスケイド・セラピューティクス・インコーポレイテッド	５−ＨＴ２Ｃリガンドとしてのテトラヒドロ−５Ｈ−ピリド［２，３−ｄ］アゼピン
PE20081834A1 (es) *	2006-12-31	2009-01-16	Boehringer Ingelheim Int	Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos
EP1975165A1 (de)	2007-03-27	2008-10-01	Boehringer Ingelheim Pharma GmbH & Co. KG	Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
EP2220079A2 (en) *	2007-11-15	2010-08-25	Boehringer Ingelheim International GmbH	Substituted amides, manufacturing and use thereof as medicaments
WO2009078999A1 (en)	2007-12-17	2009-06-25	Janssen Pharmaceutica N.V.	Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
WO2010065134A1 (en)	2008-12-05	2010-06-10	Millennium Pharmaceuticals, Inc.	5, 7-dihydro- 6h-pyrimido [ 5, 4-d] [ 1 ] benzazepin-6-thiones as plk inhibitors
JP2012517997A (ja) *	2009-02-17	2012-08-09	Ｍｓｄ株式会社	１，４−ベンゾジアゼピン−２−オン誘導体
MX2012011300A (es)	2010-03-30	2012-11-29	Sinai School Medicine	Vacunas del virus de influenza y usos de las mismas.
AU2012312529B2 (en)	2011-09-20	2018-01-04	Icahn School Of Medicine At Mount Sinai	Influenza virus vaccines and uses thereof
CN105263516A (zh)	2012-12-18	2016-01-20	西奈山伊坎医学院	流感病毒疫苗及其用途
CA2938884C (en) *	2014-02-07	2024-02-13	eXIthera Pharmaceuticals Inc.	Substituted azetidine compounds and their use as factor xia or kallikrein inhibitors
CN105622511B (zh) *	2014-11-03	2018-01-23	北京瑞都医药科技有限公司	一种减肥药物及其制备方法
EP3078378B1 (en)	2015-04-08	2020-06-24	Vaiomer	Use of factor xa inhibitors for regulating glycemia
JP7476118B2 (ja)	2018-07-05	2024-04-30	バイエル・アクチエンゲゼルシヤフト	抗菌剤としての置換チオフェンカルボキサミド類及び類縁体
CN111196772B (zh) *	2018-11-16	2022-09-30	沈阳化工研究院有限公司	一种芳酰氨基异丁酰衍生物及其应用
BR112022010333A2 (pt)	2019-12-20	2022-08-16	Bayer Ag	Tieniloxazolonas e análogos
JP7502564B2 (ja)	2020-11-06	2024-06-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	２－［（チオフェン－２－イル）ホルムアミド］－ｎ－（フェニル）－２－メチルプロパンアミド誘導体及びその医薬としての使用
WO2025019631A1 (en)	2023-07-19	2025-01-23	Icahn School Of Medicine At Mount Sinai	Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1192132B1 (en)	1999-06-14	2005-09-07	Eli Lilly And Company	Serine protease inhibitors
DE19962924A1 (de)	1999-12-24	2001-07-05	Bayer Ag	Substituierte Oxazolidinone und ihre Verwendung
BR0109356A (pt)	2000-03-21	2003-06-03	Smithkline Beecham Corp	Inibidores de protease
DE10063008A1 (de)	2000-12-16	2002-06-20	Merck Patent Gmbh	Carbonsäureamidderivate
AU2002342682A1 (en) *	2001-05-17	2002-11-25	Smithkline Beecham Corporation	Protease inhibitors
EP1562898A1 (en)	2002-11-19	2005-08-17	Takeda Pharmaceutical Company Limited	Indole derivatives as somatostatin agonists or antagonists
JP2004300133A (ja) *	2002-11-19	2004-10-28	Takeda Chem Ind Ltd	アミン誘導体
DE10254336A1 (de) *	2002-11-21	2004-06-03	Merck Patent Gmbh	Carbonsäureamide
US7250415B2 (en) *	2003-06-04	2007-07-31	Bristol-Myers Squibb Company	1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors
WO2005111013A1 (de)	2004-05-13	2005-11-24	Boehringer Ingelheim International Gmbh	Substituierte thiophen-2-carbonsäureamide, deren herstellung und deren verwendung als arzneimittel
EP1748996A1 (de) *	2004-05-13	2007-02-07	Boehringer Ingelheim International GmbH	Substituierte thiophencarbonsäureamide, deren herstellung und deren verwendung als arzneimittel
BRPI0510019A (pt)	2004-05-13	2007-09-25	Boehringer Ingelheim Int	amidas de ácido tiofenocarboxìlico substituìdas, sua preparação e seu uso como medicamento
DE102004047840A1 (de)	2004-09-29	2006-03-30	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue substituierte Thiophencarbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel
PE20081834A1 (es)	2006-12-31	2009-01-16	Boehringer Ingelheim Int	Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos

2006
- 2006-06-27 PE PE2006000745A patent/PE20070171A1/es not_active Application Discontinuation
- 2006-06-28 BR BRPI0612580A patent/BRPI0612580A8/pt not_active Application Discontinuation
- 2006-06-28 HR HR20110044T patent/HRP20110044T2/hr unknown
- 2006-06-28 ES ES06763910T patent/ES2357029T3/es active Active
- 2006-06-28 AU AU2006265216A patent/AU2006265216B2/en not_active Ceased
- 2006-06-28 UA UAA200800769A patent/UA94910C2/ru unknown
- 2006-06-28 CN CN2006800242678A patent/CN101213195B/zh not_active Expired - Fee Related
- 2006-06-28 CA CA2613059A patent/CA2613059C/en not_active Expired - Fee Related
- 2006-06-28 EA EA200702620A patent/EA015188B1/ru not_active IP Right Cessation
- 2006-06-28 SI SI200630915T patent/SI1899330T1/sl unknown
- 2006-06-28 JP JP2008517518A patent/JP4768016B2/ja not_active Expired - Fee Related
- 2006-06-28 DK DK06763910.4T patent/DK1899330T3/da active
- 2006-06-28 PT PT06763910T patent/PT1899330E/pt unknown
- 2006-06-28 NZ NZ565440A patent/NZ565440A/en not_active IP Right Cessation
- 2006-06-28 PL PL06763910T patent/PL1899330T3/pl unknown
- 2006-06-28 KR KR1020087002478A patent/KR101321722B1/ko not_active Expired - Fee Related
- 2006-06-28 WO PCT/EP2006/063611 patent/WO2007003536A1/de not_active Ceased
- 2006-06-28 SG SG201004677-9A patent/SG163540A1/en unknown
- 2006-06-28 RS RS20110015A patent/RS51572B/sr unknown
- 2006-06-28 MY MYPI20063092A patent/MY145883A/en unknown
- 2006-06-28 DE DE502006008392T patent/DE502006008392D1/de active Active
- 2006-06-28 MX MX2007016253A patent/MX2007016253A/es active IP Right Grant
- 2006-06-28 US US11/993,426 patent/US20100216769A1/en not_active Abandoned
- 2006-06-28 AT AT06763910T patent/ATE489381T1/de active
- 2006-06-28 EP EP06763910A patent/EP1899330B9/de active Active
- 2006-06-29 TW TW095123603A patent/TWI392495B/zh not_active IP Right Cessation
- 2006-06-30 AR ARP060102825A patent/AR054627A1/es active IP Right Grant
2007
- 2007-10-05 ZA ZA200708525A patent/ZA200708525B/xx unknown
- 2007-10-11 NO NO20075186A patent/NO340670B1/no not_active IP Right Cessation
- 2007-12-20 IL IL188323A patent/IL188323A/en not_active IP Right Cessation
- 2007-12-27 EC EC2007008058A patent/ECSP078058A/es unknown
2011
- 2011-02-16 CY CY20111100202T patent/CY1111627T1/el unknown
2013
- 2013-03-05 US US13/785,176 patent/US9062034B2/en active Active
2015
- 2015-05-19 US US14/716,227 patent/US9676781B2/en active Active

Also Published As

Publication number	Publication date
US20100216769A1 (en)	2010-08-26
AU2006265216B2 (en)	2011-09-29
NO340670B1 (no)	2017-05-29
TW200738692A (en)	2007-10-16
JP4768016B2 (ja)	2011-09-07
CN101213195B (zh)	2012-05-09
BRPI0612580A8 (pt)	2017-12-26
US20130184256A1 (en)	2013-07-18
EA015188B1 (ru)	2011-06-30
CY1111627T1 (el)	2015-10-07
AR054627A1 (es)	2007-07-04
NZ565440A (en)	2011-04-29
DE502006008392D1 (de)	2011-01-05
HRP20110044T1 (hr)	2011-02-28
SI1899330T1 (sl)	2011-03-31
EA200702620A1 (ru)	2008-06-30
US20150252050A1 (en)	2015-09-10
EP1899330B1 (de)	2010-11-24
CA2613059A1 (en)	2007-01-11
US9062034B2 (en)	2015-06-23
CA2613059C (en)	2013-12-24
NO20075186L (no)	2008-02-14
AU2006265216A1 (en)	2007-01-11
PT1899330E (pt)	2011-01-11
KR20080033318A (ko)	2008-04-16
RS51572B (sr)	2011-08-31
PL1899330T3 (pl)	2011-05-31
ES2357029T3 (es)	2011-04-15
JP2008546741A (ja)	2008-12-25
HRP20110044T2 (hr)	2012-02-29
EP1899330A1 (de)	2008-03-19
MY145883A (en)	2012-05-15
BRPI0612580A2 (pt)	2010-11-23
WO2007003536A1 (de)	2007-01-11
US9676781B2 (en)	2017-06-13
CN101213195A (zh)	2008-07-02
ATE489381T1 (de)	2010-12-15
PE20070171A1 (es)	2007-03-08
HK1116190A1 (en)	2008-12-19
ECSP078058A (es)	2008-01-23
ZA200708525B (en)	2009-08-26
MX2007016253A (es)	2008-03-07
EP1899330B9 (de)	2011-11-09
KR101321722B1 (ko)	2013-10-25
IL188323A (en)	2013-08-29
UA94910C2 (ru)	2011-06-25
TWI392495B (zh)	2013-04-11
IL188323A0 (en)	2008-04-13
DK1899330T3 (da)	2011-02-21

Publication	Publication Date	Title
WO2007131982A3 (de)	2008-01-10	Substituierte prolinamide, deren herstellung und deren verwendung als arzneimittel
SG163540A1 (en)	2010-08-30	Substituted glycinamides having an antithrombotic and factor xa- inhibiting effect
WO2009065919A3 (de)	2009-10-01	Organische verbindungen
WO2009065920A3 (de)	2009-10-15	Verbindungen
TW200602033A (en)	2006-01-16	New carboxylic acid amides, the preparation thereof and their use as medicaments
MX2010003849A (es)	2010-04-27	Antagonistas de cgrp.
TW200504032A (en)	2005-02-01	New carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
TW200504067A (en)	2005-02-01	New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
WO2009065922A3 (de)	2009-10-01	Organische verbindungen
WO2006105888A3 (de)	2007-03-15	Synergistische fungizide wirkstoffkombinationen
SG169339A1 (en)	2011-03-30	Aryl sulfonamides with an analgesic action
TNSN07272A1 (en)	2008-12-31	Substituted bis aryl and heteroaryl compounds as selective 5ht 2a antagonists
WO2005103037A3 (de)	2006-01-12	Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2007036532A3 (de)	2007-06-21	Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
ATE478054T1 (de)	2010-09-15	Benzimidazolderivate
WO2006100082A3 (de)	2006-12-07	Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
TN2010000072A1 (en)	2011-09-26	New compounds
MY148769A (en)	2013-05-31	Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
NO20070089L (no)	2007-01-05	DPP-IV inhibitorer
TW200604178A (en)	2006-02-01	New substituted thiophene carboxamides, process for their preparation and their use as medicaments
WO2009034029A3 (de)	2009-07-09	1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten
EA200500261A1 (ru)	2005-08-25	Новые пролекарства (n-2-пиридил-n-2-гидроксикарбонилэтил)амида 1-метил-2-(4-амидинофениламинометил)бензимидазол-5-илкарбоновой кислоты, их получение и их применение в качестве лекарственных средств
WO2008135525A3 (en)	2008-12-31	Substituted azetidines, manufacturing and use thereof as medicaments
TW200722424A (en)	2007-06-16	Substituted piperidines
UA88956C2 (ru)	2009-12-10	Синергическая фунгицидная комбинация действующих веществ